Varma Mutual Pension Insurance Co Sells 6,200 Shares of Cardinal Health, Inc. $CAH

Key Points

• Varma Mutual Pension Insurance Co cut its stake in Cardinal Health by 9.9%, selling 6,200 shares and leaving 56,400 shares valued at about $11.59 million.
• Cardinal Health beat EPS expectations with $3.17 for the quarter (vs. $2.79 est.) but missed revenue estimates at $60.94 billion; it set FY2026 guidance of 10.70–10.80 EPS and carries an analyst consensus of "Moderate Buy" with an average price target of $241.80.
• The company raised its quarterly dividend to $0.5158 (annualized $2.06), implying a ~1.0% yield and a payout ratio of about 31.2%.

Varma Mutual Pension Insurance Co lessened its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 9.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 56,400 shares of the company's stock after selling 6,200 shares during the period. Varma Mutual Pension Insurance Co's holdings in Cardinal Health were worth $11,590,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Aventura Private Wealth LLC bought a new position in shares of Cardinal Health in the fourth quarter worth approximately $25,000. Barnes Dennig Private Wealth Management LLC lifted its stake in shares of Cardinal Health by 38.7% in the fourth quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company's stock worth $39,000 after buying an additional 53 shares in the last quarter. JPL Wealth Management LLC bought a new position in shares of Cardinal Health in the third quarter worth approximately $31,000. Turning Point Benefit Group Inc. bought a new position in Cardinal Health during the third quarter valued at approximately $31,000. Finally, Cape Investment Advisory Inc. lifted its position in Cardinal Health by 61.1% during the third quarter. Cape Investment Advisory Inc. now owns 211 shares of the company's stock valued at $33,000 after purchasing an additional 80 shares during the period. Institutional investors own 87.17% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Mizuho increased their price objective on shares of Cardinal Health from $222.00 to $235.00 and gave the company an "outperform" rating in a research report on Friday, February 6th. UBS Group set a $260.00 price objective on shares of Cardinal Health and gave the company a "buy" rating in a research report on Friday, February 6th. Barclays increased their price objective on shares of Cardinal Health from $243.00 to $258.00 and gave the company an "overweight" rating in a research report on Tuesday, February 24th. Wells Fargo & Company lowered their price objective on shares of Cardinal Health from $256.00 to $245.00 and set an "overweight" rating on the stock in a research report on Friday, May 1st. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Cardinal Health from $243.00 to $215.00 and set a "neutral" rating on the stock in a research report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $241.80.

Cardinal Health Trading Down 0.0%

Shares of CAH stock opened at $196.97 on Wednesday. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $233.60. The stock has a market cap of $46.13 billion, a P/E ratio of 30.12, a P/E/G ratio of 1.17 and a beta of 0.53. The company has a 50 day simple moving average of $213.19 and a two-hundred day simple moving average of $206.47.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating analysts' consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business had revenue of $60.94 billion during the quarter, compared to analysts' expectations of $62.10 billion. During the same period in the prior year, the company earned $2.35 earnings per share. The firm's revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts forecast that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Wednesday, July 1st. Cardinal Health's dividend payout ratio is currently 31.19%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.